RxDoctor Payments Data

Pedro Flores, MD

Family Medicine · Lakeland, FLNPI 1619168218

Payments from drug & device makers

$1,592in general payments, 2019–2025

Across 92 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$577
  • Lilly USA, LLC$247
  • Merck$168
  • AbbVie$147
  • Amarin Pharma, Inc.$143
  • Novo Nordisk$74
  • plus $236 from 8 others

What the payments were for

  • Food & beverage$1,592100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,592 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$91,783
Medicare patients
240
Services billed
931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$117,165
JardianceEmpagliflozin72$94,700
EliquisApixaban69$88,640
FarxigaDapagliflozin Propanediol54$71,993
MounjaroTirzepatide54$71,940
ArexvyRsvpref3 Antigen/As01e/Pf198$59,764
XareltoRivaroxaban24$25,894
JanumetSitagliptin Phos/Metformin Hcl19$25,300
JanuviaSitagliptin Phosphate15$24,482
TrulicityDulaglutide21$21,209
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$14,294
VascepaIcosapent Ethyl13$11,961
Atorvastatin Calcium765$8,853
Rosuvastatin Calcium540$7,413
Breo ElliptaFluticasone/Vilanterol19$7,275

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$74$117,16590 claims
Boehringer IngelheimJardiance$31$94,70072 claims
Lilly USA, LLCMounjaro, Trulicity$247$93,14975 claims
PfizerEliquis$21$88,64069 claims
GSKArexvy, Trelegy Ellipta, Breo Ellipta, Shingrix$22$83,951247 claims
AstraZenecaFarxiga, Symbicort$577$78,61072 claims
MerckJanumet, Januvia$168$49,78334 claims
AbbVieSynthroid$147$4,46956 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →